Orchidectomy versus oestrogen for prostatic cancer: cardiovascular effects.
作者信息
Meade T W
出版信息
Br Med J (Clin Res Ed). 1986 Oct 11;293(6552):953-4. doi: 10.1136/bmj.293.6552.953-a.
Abstract
摘要
相似文献
1
Orchidectomy versus oestrogen for prostatic cancer: cardiovascular effects.睾丸切除术与雌激素治疗前列腺癌：心血管影响
Br Med J (Clin Res Ed). 1986 Oct 11;293(6552):953-4. doi: 10.1136/bmj.293.6552.953-a.
2
Orchidectomy versus oestrogen for prostatic cancer: cardiovascular effects.睾丸切除术与雌激素治疗前列腺癌：心血管效应
Br Med J (Clin Res Ed). 1986 Aug 16;293(6544):413-5. doi: 10.1136/bmj.293.6544.413.
3
Orchidectomy and oestrogen therapy revisited.
Eur Urol. 1998;34 Suppl 3:7-11. doi: 10.1159/000052290.
4
Orchidectomy versus oestrogen for prostatic cancer.前列腺癌的睾丸切除术与雌激素治疗对比
Br Med J (Clin Res Ed). 1986 Oct 25;293(6554):1100-1. doi: 10.1136/bmj.293.6554.1100-c.
5
Activators and inhibitors of coagulation and fibrinolysis in patients with prostatic cancer treated with oestrogen or orchidectomy.
Thromb Res. 1986 Dec 15;44(6):783-91. doi: 10.1016/0049-3848(86)90024-1.
6
Cost comparison of parenteral estrogen and conventional hormonal treatment in patients with prostatic cancer.前列腺癌患者肠外雌激素与传统激素治疗的成本比较。
Int J Technol Assess Health Care. 1991;7(2):220-5. doi: 10.1017/s0266462300005110.
7
[Cardiovascular complications of oestrogen treatment in prostatic carcinoma (author's transl)].
Ther Umsch. 1978 Oct;35(10):841-4.
8
Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: evaluation of cardiovascular events in a randomized trial.915例转移性前列腺癌患者接受胃肠外雌激素治疗或联合雄激素剥夺治疗期间，预处理心血管疾病作为危险因素的意义：一项随机试验中心血管事件的评估
Scand J Urol Nephrol. 2011 Nov;45(5):346-53. doi: 10.3109/00365599.2011.585820. Epub 2011 May 31.
9
Deleterious effects of low-dose oestrogen therapy on coronary status in patients with prostatic cancer.低剂量雌激素疗法对前列腺癌患者冠状动脉状况的有害影响。
Eur Heart J. 1987 Jul;8(7):779-84. doi: 10.1093/eurheartj/8.7.779.
10
Patients at high risk of cardiovascular complications in oestrogen treatment of prostatic cancer.前列腺癌雌激素治疗中心血管并发症高危患者。
Br J Urol. 1989 Feb;63(2):186-90. doi: 10.1111/j.1464-410x.1989.tb05162.x.
本文引用的文献
1
Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations.孕激素与口服避孕药相关的心血管反应以及50微克和30微克雌激素制剂安全性的比较。
Br Med J. 1980 May 10;280(6224):1157-61. doi: 10.1136/bmj.280.6224.1157.
2
An association between the factor VII coagulant activity and thrombin activity induced by surface/cold exposure of normal human plasma.
Br J Haematol. 1986 Feb;62(2):379-84. doi: 10.1111/j.1365-2141.1986.tb02941.x.
3
Serological tests for leprosy.
Lancet. 1986 Mar 8;1(8480):533-5.
4
Haemostatic, lipid, and blood-pressure profiles of women on oral contraceptives containing 50 microgram or 30 microgram oestrogen.
Lancet. 1977 Nov 5;2(8045):948-51. doi: 10.1016/s0140-6736(77)90888-1.
Zotero 插件